Provided by Tiger Fintech (Singapore) Pte. Ltd.

Forte BioSciences Inc

10.79
-0.8400-7.22%
Volume:21.61K
Turnover:242.40K
Market Cap:131.79M
PE:-1.31
High:11.89
Open:11.89
Low:10.71
Close:11.63
Loading ...

BUZZ-U.S. STOCKS ON THE MOVE-Coinbase, Rubrik, AeroVironment

Reuters
·
26 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Array Technologies, Viking Therapeutics, Winnebago

Reuters
·
25 Jun

BUZZ-Forte Biosciences slides on planned equity offering

Reuters
·
25 Jun

BRIEF-Forte Biosciences Announces Proposed Public Offering

Reuters
·
25 Jun

Forte Biosciences announces common stock offering, no amount given

TIPRANKS
·
25 Jun

Forte Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
24 Jun

Forte Biosciences Stock (FBRX) Surges 25% on Positive Celiac Disease Trial Data

TIPRANKS
·
23 Jun

BRIEF-Forte Biosciences Announces Positive Data In Fb102 Celiac Disease Phase 1B Study

Reuters
·
23 Jun

Forte Biosciences Announces Positive Phase 1B Trial Results for Celiac Disease Treatment FB102, Phase 2 Study to Begin

Reuters
·
23 Jun

Forte Biosciences initiated with a Buy at Lucid Capital

TIPRANKS
·
05 Jun

Forte Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
30 May

Top Premarket Decliners

MT Newswires Live
·
19 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
19 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
16 May

TD Cowen Remains a Buy on Forte Biosciences (FBRX)

TIPRANKS
·
16 May

Forte Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
16 May

BRIEF-Forte Biosciences Q1 Operating Expenses USD 16.124 Million

Reuters
·
16 May

Forte Biosciences Q1 EPS $(1.37) Misses $(0.96) Estimate

Benzinga
·
16 May

Forte Biosciences Reports Increased Q1 2025 Net Loss of $15.7M and EPS of $(1.37) Amid Higher R&D Expenses

Reuters
·
16 May

Forte Biosciences Inc expected to post a loss of 95 cents a share - Earnings Preview

Reuters
·
09 May